Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

PD1 drugs could end ‘decades of silence’ in bladder cancer therapy

Merck's Keytruda and Roche antibody showing promise

- PMLiVE

Janssen, AZ and Roche at ESMO

Companies present promising data on new cancer drugs

- PMLiVE

Amag buys into maternal health business

Will acquire female health specialist Lumara Health

- PMLiVE

Alacrita appoints Stuart Hendry as associate partner

Joins from medical device firm Sphere Medical

Daiichi Sankyo logo

Japan’s Daiichi Sankyo pays $410m for Ambit Biosciences

Gains rights to cancer drug quizartinib

- PMLiVE

EMA wants to embed patient viewpoint within drug assessment

Will pilot CHMP benefit-risk evaluation project

Gilead Sciences

Gilead’s hep C combination Harvoni recommended for EU approval

CHMP backs combination of Sovaldi and ledipasvir

- PMLiVE

Virgo Health names US head

Nancy Caravetta to lead the UK comms agency's new PR practice in New York

- PMLiVE

Sales reps struggle to access doctors

Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information

Sanofi reception

Sanofi provides bursaries to UK patient groups

Older People's Advocacy Alliance receives gold award of £25,000

The benefits of Big Data

Using real-world patient outcomes data

EU flag

EMA backs 15 new medicines for use in EU

Includes new treatments from Gilead, Lilly, Boehringer, AstraZeneca and Janssen

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links